Universal Beteiligungs und Servicegesellschaft mbH Purchases Shares of 428,107 Stryker Co. (NYSE:SYK)

Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Stryker Co. (NYSE:SYK - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 428,107 shares of the medical technology company's stock, valued at approximately $154,140,000. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.11% of Stryker as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Bernard Wealth Management Corp. bought a new position in shares of Stryker during the fourth quarter valued at approximately $188,000. Capital A Wealth Management LLC bought a new position in Stryker during the 4th quarter worth $26,000. Financial Advisory Corp acquired a new stake in Stryker in the fourth quarter worth $310,000. Lakeshore Capital Group Inc. bought a new stake in Stryker in the fourth quarter valued at $850,000. Finally, Heck Capital Advisors LLC acquired a new position in shares of Stryker during the fourth quarter valued at $662,000. 77.09% of the stock is owned by institutional investors.

Insider Activity at Stryker

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the business's stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total value of $75,392,000.00. Following the sale, the director now directly owns 3,417,326 shares of the company's stock, valued at approximately $1,288,195,208.96. The trade was a 5.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 5.20% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the company. BTIG Research set a $403.00 price target on Stryker and gave the stock a "buy" rating in a research report on Monday, April 14th. JPMorgan Chase & Co. upped their price objective on shares of Stryker from $420.00 to $445.00 and gave the stock an "overweight" rating in a report on Wednesday, January 29th. Stifel Nicolaus raised their target price on shares of Stryker from $400.00 to $440.00 and gave the company a "buy" rating in a research note on Wednesday, January 29th. Needham & Company LLC restated a "buy" rating and issued a $442.00 target price on shares of Stryker in a research report on Friday, March 21st. Finally, Royal Bank of Canada raised their price objective on shares of Stryker from $425.00 to $435.00 and gave the company an "outperform" rating in a research report on Wednesday, January 29th. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $427.30.

Stryker Stock Performance

NYSE:SYK traded up $1.73 on Thursday, reaching $382.12. 840,274 shares of the company's stock were exchanged, compared to its average volume of 1,342,547. Stryker Co. has a 52 week low of $314.93 and a 52 week high of $406.19. The stock has a fifty day simple moving average of $368.42 and a 200-day simple moving average of $376.23. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. The firm has a market cap of $145.85 billion, a price-to-earnings ratio of 49.24, a P/E/G ratio of 2.93 and a beta of 0.93.

Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.84 earnings per share for the quarter, topping the consensus estimate of $2.73 by $0.11. The company had revenue of $5.87 billion for the quarter, compared to analysts' expectations of $5.68 billion. Stryker had a net margin of 13.25% and a return on equity of 23.58%. Stryker's revenue for the quarter was up 11.9% compared to the same quarter last year. During the same period in the prior year, the business earned $2.50 earnings per share. As a group, sell-side analysts predict that Stryker Co. will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be paid a dividend of $0.84 per share. The ex-dividend date is Monday, June 30th. This represents a $3.36 annualized dividend and a dividend yield of 0.88%. Stryker's dividend payout ratio (DPR) is presently 45.41%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.